| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
From the Canadian Field Epidemiology Program (Cutler), the Canadian Public Health Service (Schleihauf) and the National Microbiology Laboratory (Li, Bastien), Public Health Agency of Canada, Ottawa, Ont.; the Nova Scotia Department of Health Promotion and Protection (Cutler, Schleihauf, Billard, Watson-Creed, Sarwal), Halifax, NS; the Division of Microbiology (Hatchette, Davidson), Department of Pathology and Laboratory Medicine, Capital District Health Authority, Halifax, NS; and the Departments of Pathology (Hatchette, Davidson), Community Health and Epidemiology (Watson-Creed, Sarwal), and Microbiology and Immunology (Davidson), Dalhousie University, Halifax, NS
Correspondence to: Dr. Shelly Sarwal, 1601 Lower Water St., P.O. Box 487, Halifax NS B3J 2R7; fax 902 428-3313; shelly.sarwal{at}gov.ns.ca
The outbreak of human infection due to the novel swine-origin influenza A (H1N1) virus began in Mexico in March 2009. As of July 6, 2009, more than 94 000 laboratory-confirmed cases were reported in over 100 countries, including 7983 cases in Canada. In this report, we describe the epidemiologic and clinical characteristics of the first cluster of reported cases of human-to-human transmission of the new influenza virus in Canada.
Related Articles
This article has been cited by other articles:
![]() |
The ANZIC Influenza Investigators Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand N. Engl. J. Med., November 12, 2009; 361(20): 1925 - 1934. [Abstract] [Full Text] [PDF] |
||||